Tatsuhiko Ozawa, Yoshiki Ikeda, Liuan Chen, Rigel Suzuki, Atsushi Hoshino, Akira Noguchi, Shunsuke Kita, Yuki Anraku, Emiko Igarashi, Yumiko Saga, et al. Rational in silico design identifies two mutations that restore UT28K SARS-CoV-2 monoclonal antibody activity against Omicron BA.1. Structure (London, England : 1993). 2024
Kentaro Uemura, Haruaki Nobori, Akihiko Sato, Shinsuke Toba, Shinji Kusakabe, Michihito Sasaki, Koshiro Tabata, Keita Matsuno, Naoyoshi Maeda, Shiori Ito, et al. 2-thiouridine is a broad-spectrum antiviral nucleoside analogue against positive-strand RNA viruses. Proceedings of the National Academy of Sciences of the United States of America. 2023. 120. 42. e2304139120
Saya Moriyama, Yuki Anraku, Shunta Taminishi, Yu Adachi, Daisuke Kuroda, Shunsuke Kita, Yusuke Higuchi, Yuhei Kirita, Ryutaro Kotaki, Keisuke Tonouchi, et al. Structural delineation and computational design of SARS-CoV-2-neutralizing antibodies against Omicron subvariants. Nature communications. 2023. 14. 1. 4198-4198
Tomokazu Tamura, Jumpei Ito, Keiya Uriu, Jiri Zahradnik, Izumi Kida, Yuki Anraku, Hesham Nasser, Maya Shofa, Yoshitaka Oda, Spyros Lytras, et al. Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants. Nature communications. 2023. 14. 1. 2800-2800
山本旭麻, 東浦彰史, 下岡清美, 河野洋平, 喜多俊介, 安楽佑樹, 橋口隆生, 前仲勝実, 保田朋波流, 坂口剛正. Neutralization mechanism revealed by structural analysis of SARS CoV-2 spike protein complexed with antibodies. 日本ウイルス学会学術集会プログラム・予稿集(Web). 2023. 70th
矢島久乃, 安楽佑樹, 喜多俊介, 佐々木慈英, 木村(寺角)香菜子, 前仲勝実, 佐藤佳, 福原崇介, 橋口隆生. Cryo-EM structure of SARS-CoV-2 XBB.1.5 spike protein and its ACE2 receptor recognition mechanism and structural comparison with XBB.1. 日本ウイルス学会学術集会プログラム・予稿集(Web). 2023. 70th
安楽佑樹, 喜多俊介, 矢島久乃, 佐藤佳, 橋口隆生, 前仲勝実. Structural analysis of SARS-CoV-2 XBB.1 spike protein and ACE2 complex. 日本ウイルス学会学術集会プログラム・予稿集(Web). 2023. 70th
染谷太陽, 安楽佑樹, 森山彩野, 橋口隆生, 高橋宜聖, 喜多俊介, 前仲勝実. Analysis of the relationship between neutralizing activity and antigen recognition mechanism based on the structure of NIV antibody and SARS-CoV-2 spike protein complex. 日本ウイルス学会学術集会プログラム・予稿集(Web). 2023. 70th